Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine in Septic Shock Recovery
NCT02771158Phase 4Withdrawn
- Sponsor
- Northwell Health
- Start
- Aug 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in septic shock comparing Midodrine Arm with Placebo Arm (2 arms). Primary endpoint: duration of intravenous vasopressors. Planned start Aug 2017; status: withdrawn.
02
Drugs
midodrine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02771158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02771158.